GLP1 receptor agonists are looking like longevity drugs. A new...

@davidasinclair
David Sinclair@davidasinclair
27 views Mar 19, 2025 ~1 min read
Advertisement
1
GLP1 receptor agonists are looking like longevity drugs. A new study reports that drug-induced improvements in bone mass are mediated by the NAD-dependent SIRT1 enzyme.
If so, could NAD boosters work with GLP-1 drugs? Some thoughts...🧵
Media image
2
This new study is consistent with studies showing NMN, an NAD booster & SIRT1 activator, improves bone mass in mice
Media image
3
This paper summarizes the evidence that GLP1RA drugs benefits bone
Media image
4
NMN has been shown in mice to improve healing of broken bones..
Media image
5
And this one on SIRT1's benefits on bone:
Media image
6
But be aware that these drugs can have negative side effects on the kidney, muscle and even increase the chances of sudden blindness! jamanetwork.com/journals/jamao…
7
Here's the link to the new paper on GLP-1RA brieflands.com/articles/ijpr-…
9
Another side effect of GLP-1RA is muscle loss. Perhaps NAD boosters could help with this side effect, especially given there is evidence from a small study @BrighamWomens that people have more leg endurance after 4 weeks on NMN
Media image
10
Here's more on that study:
nad.com/news/harvard-s…
Actions
What You Can Do
  • Export as PDF or Markdown
  • Batch Export to Notion
  • Bookmark & Highlight
  • Screenshot Tweet
Create Free Account

Includes 7-day Premium trial

Advertisement